Philip S. Insel

Overview

Best Publications

• Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials.

  Lon S. Schneider;Karen S. Dagerman;Philip Insel

  2042
  Citations

• Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials.

  Lon S. Schneider;Karen Dagerman;Philip S. Insel

  1057
  Citations

• Development and assessment of a composite score for memory in the Alzheimer’s Disease Neuroimaging Initiative (ADNI)

  Paul K. Crane;Adam Carle;Laura E. Gibbons;Philip Insel

  676
  Citations

• A composite score for executive functioning, validated in Alzheimer's Disease Neuroimaging Initiative (ADNI) participants with baseline mild cognitive impairment

  Laura E. Gibbons;Adam C. Carle;R. Scott Mackin;Danielle J Harvey

  560
  Citations

• Spread of pathological tau proteins through communicating neurons in human Alzheimer's disease

  Jacob W. Vogel;Yasser Iturria-Medina;Olof T. Strandberg;Ruben Smith

  522
  Citations

• Plasma tau in Alzheimer disease

  Niklas Mattsson;Henrik Zetterberg;Henrik Zetterberg;Henrik Zetterberg;Shorena Janelidze;Philip S. Insel

  505
  Citations

• Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease

  Sebastian Palmqvist;Philip S Insel;Philip S Insel;Erik Stomrud;Shorena Janelidze

  378
  Citations

• Aβ deposition is associated with increases in soluble and phosphorylated tau that precede a positive Tau PET in Alzheimer's disease.

  Niklas Mattsson-Carlgren;Emelie Andersson;Shorena Janelidze;Rik Ossenkoppele;Rik Ossenkoppele

  339
  Citations

• Associations between tau, Aβ, and cortical thickness with cognition in Alzheimer disease.

  Rik Ossenkoppele;Ruben Smith;Tomas Ohlsson;Olof Strandberg

  309
  Citations

• Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease.

  Niklas Mattsson;Philip S Insel;Philip S Insel;Sebastian Palmqvist;Erik Portelius

  307
  Citations

• Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease.

  Niklas Mattsson;Niklas Mattsson;Niklas Mattsson;Philip S. Insel;Philip S. Insel;Michael Donohue;Susan Landau

  255
  Citations

• Serum Neurofilament Light Chain for Prognosis of Outcome After Cardiac Arrest.

  Marion Moseby-Knappe;Niklas Mattsson;Niklas Nielsen;Henrik Zetterberg

  239
  Citations

• Magnetic resonance imaging in Alzheimer's Disease Neuroimaging Initiative 2

  Clifford R. Jack;Josephine Barnes;Matt A. Bernstein;Bret J. Borowski

  234
  Citations

• Association of brain amyloid-β with cerebral perfusion and structure in Alzheimer’s disease and mild cognitive impairment

  Niklas Mattsson;Niklas Mattsson;Niklas Mattsson;Duygu Tosun;Duygu Tosun;Philip S. Insel;Philip S. Insel;Alix Simonson;Alix Simonson

  207
  Citations

• Early stages of tau pathology and its associations with functional connectivity, atrophy and memory.

  David Berron;Jacob W Vogel;Philip S Insel;Philip S Insel;Joana B Pereira

  205
  Citations

• 18F-AV-1451 and CSF T-tau and P-tau as biomarkers in Alzheimer's disease

  Niklas Mattsson;Michael Schöll;Olof Strandberg;Ruben Smith

  186
  Citations

• Treatment With Cholinesterase Inhibitors and Memantine of Patients in the Alzheimer’s Disease Neuroimaging Initiative

  Lon S. Schneider;Philip S. Insel;Michael W. Weiner

  162
  Citations

• Cognitive reserve associated with FDG-PET in preclinical Alzheimer disease.

  Michael Ewers;Philip S. Insel;Yaakov Stern;Michael W. Weiner

  152
  Citations

• The Brain Health Registry: An internet-based platform for recruitment, assessment, and longitudinal monitoring of participants for neuroscience studies

  Michael W. Weiner;Rachel Nosheny;Rachel Nosheny;Monica Camacho;Monica Camacho;Diana Truran-Sacrey

  148
  Citations

• Mild behavioral impairment and its relation to tau pathology in preclinical Alzheimer's disease.

  Maurits Johansson;Erik Stomrud;Philip S. Insel;Antoine Leuzy

  144
  Citations

• Hippocampal atrophy rates and CSF biomarkers in elderly APOE2 normal subjects

  G. C. Chiang;G. C. Chiang;P. S. Insel;D. Tosun;D. Tosun;N. Schuff;N. Schuff

  115
  Citations